Development of pumping emulsification device with glass membrane to form ideal lipiodol emulsion in transarterial chemoembolization
Autor: | Shushi Higashi, Kimihiko Kichikawa, Yasushi Fukuoka, Takeshi Sato, Shota Tatsumoto, Nagaaki Marugami, Hideyuki Nishiofuku, Toshihiro Tanaka, Tetsuya Masada |
---|---|
Rok vydání: | 2017 |
Předmět: |
Pore size
medicine.medical_specialty Carcinoma Hepatocellular 030218 nuclear medicine & medical imaging 03 medical and health sciences Ethiodized Oil 0302 clinical medicine Catheterization Peripheral medicine Humans Infusions Intra-Arterial Radiology Nuclear Medicine and imaging New device Chemoembolization Therapeutic business.industry Liver Neoplasms General Medicine Membrane 030220 oncology & carcinogenesis Emulsion Lipiodol Emulsions Radiology business Biomedical engineering medicine.drug |
Zdroj: | European Radiology. 28:2203-2207 |
ISSN: | 1432-1084 0938-7994 |
DOI: | 10.1007/s00330-017-5197-x |
Popis: | To evaluate a pumping emulsification device that can improve the physiochemical properties and stability of lipiodol emulsion for conventional transarterial chemoembolization. A pumping emulsification device constructed of a glass membrane with a hydrophobic surface with pore size of 50 μm in diameter was placed between two syringe adaptors. Epirubicin solutions were mixed with lipiodol with pumping exchanges using the emulsification device or a three-way cock. The ratios of epirubicin solution to lipiodol were 1:2 or 1:1. A total of 120 emulsions were created. The emulsification device showed significantly higher percentages of water-in-oil when compared with the three-way cock (97.9 % vs. 68.9 % in 1:2 ratio, and 82.1 % vs. 17.8 % in 1:1 ratio, p < .001). Droplet sizes in the emulsification device were more homogenous. Mean droplet sizes and viscosities in the emulsification device did not show any significant changes for 30 min after pumping, whereas in the three-way cock, the droplet sizes significantly enlarged and viscosities significantly decreased (p=.023 and p=.002). The emulsification device can form a high percentage of water-in-oil emulsion with stable droplets sizes and viscosities. This developed device is promising to increase therapeutic effects in conventional transarterial chemoembolization. • We developed new device for transarterial chemoembolization for liver cancer. • The device can improve the physiochemical properties of lipiodol emulsion. • The device can increase the therapeutic effects in conventional transarterial chemoembolization. |
Databáze: | OpenAIRE |
Externí odkaz: |